Log In
Print this Print this

teplizumab (MGA031)

  Manage Alerts
Collapse Summary General Information
Company MacroGenics Inc.
DescriptionHumanized mAb against CD3
Molecular Target CD3
Mechanism of ActionBinds CD3; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsIslet transplant; Treat recent-onset Type I diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today